Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
June 30, 2026
Rare cancer diagnosis leads Oregon man to leading-edge care at Fred Hutch
After facial paralysis revealed an uncommon form of skin cancer, Bob Duncan turned to proton therapy and a clinical trial
Here comes the sun! What’s your skin strategy?
Avoiding sunburn is the first step in preventing deadly skin cancer melanoma
Had radiation? Protect your skin from the sun!
Skin that has been exposed to radiation therapy can be more sensitive to the sun’s UV rays
Skin in the game: Changing the story of Merkel cell carcinoma
How the Nghiem Lab and its supporters are improving outcomes for patients with a rare cancer
Discovery of a hidden tumor suppressor in the genome of the virus that causes Merkel cell carcinoma
From the Galloway Lab, Human Biology Division
The Beam: Proton therapy for rare cancers, an in-depth look at our team coordinators’ role and meet new medical assistant
Proton therapy’s role in the treatment of less common cancer, learn what proton therapy coordinators do and an introduction to Jade Duke, MA
New biomarker could one day help tailor immunotherapy for Merkel cell carcinoma
Helps explain why only certain MCC patients respond to immune checkpoint inhibitors, could point toward new strategies to improve treatment responses
Macrophages predict response to immunotherapy in Merkel cell carcinoma
From the Nghiem lab, Fred Hutch Clinical Research Division & UW Dermatology
Untangling how body location promotes cancer
Beronja Lab postdoc Rachel Lex receives ACS fellowship to uncover regional factors driving tumor development
Two opposing “agendas” keep skin mutant cell clusters at an impasse
From the Beronja lab, Human Biology Division
Hutch science featured at world's premier cancer immunotherapy meeting
Researchers honored at SITC 2018 for work on immune-based treatments for leukemia, ovarian cancer, skin cancer
Researchers identify new way skin stops tumor growth
‘Oncogene-induced differentiation’ joins two other strategies for counteracting potentially cancer-causing DNA changes
Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma
‘Incredibly big change’ in treatment of deadly skin cancer, new data show
7 skin cancer myths — debunked
Experts take on base tans and other ‘complete baloney’ standing in the way of skin health
Immunotherapy drug becomes first therapy approved by FDA for rare skin cancer
Benefit seen in nearly one-third of patients ‘with no hope at all of surviving’ their treatment-resistant Merkel cell carcinoma
Scratching the surface of a rare skin cancer
Immune-boosting therapy shows promise for advanced Merkel cell carcinoma